• 4-Ethylphenyl Sulfate: Assay Workflows

  2026-09-19

  Learn how 4-ethylphenyl sulfate can support renal biomarker assays, metabolite-surface adsorption studies, and gut microbiota-brain interaction research. This workflow-focused guide emphasizes matrix controls, mass-spectrometry readiness, storage, and troubleshooting for more reproducible results.

• CCR5-Positive EVs in Rheumatoid Arthritis

  2026-09-18

  The reference study identifies CCR5-bearing extracellular vesicles released by rheumatoid arthritis synovial fibroblasts as active mediators of cartilage destruction, bone erosion, and NF-κB-associated inflammation. Its combined in vitro and adjuvant-induced arthritis experiments suggest that removing or pharmacologically blocking EV-associated CCR5 can reduce pathogenic signaling, while also defining important limits for translating this mechanism into therapy.

• GDC-0994: ERK1/2 Inhibitor Workflow Guide

  2026-09-18

  GDC-0994 provides a selective way to test whether ERK1/2 signaling drives tumor cell proliferation or estrogen-associated cholestatic injury. This practical guide connects target-engagement assays, zebrafish liver models, oncology workflows, and troubleshooting strategies around one experimentally tractable ERK pathway inhibitor.

• EX 527 for SIRT1 Mechanism Studies

  2026-09-17

  EX 527 (SEN0014196) enables selective interrogation of SIRT1 catalytic activity across p53, DNA-damage, vascular, and osteogenic models. Its biochemical potency and strong selectivity over SIRT2 and SIRT3 make it useful for separating SIRT1-dependent phenotypes from broader sirtuin effects.

• PD0325901: Reliable MEK Inhibition Workflows

  2026-09-17

  This scenario-driven guide explains how PD0325901 (SKU A3013) can improve interpretation of viability, proliferation, cytotoxicity, and pathway-inhibition assays. It connects practical stock preparation, orthogonal readouts, experimental controls, and vendor-selection criteria with documented MEK, cell-cycle, apoptosis, and xenograft findings.

• Arrb2, 6-ketoLCA, and Hepatic IRI

  2026-09-16

  The reference study identifies hepatocyte Arrb2 as a regulator of macrophage behavior during hepatic ischemia–reperfusion injury, connecting increased 6-ketoLCA with M2 polarization and reduced tissue damage. Its combination of clinical samples, hepatocyte-focused mouse genetics, hypoxia–reoxygenation experiments, and metabolite analysis offers a useful framework for mechanistic liver transplantation research.

• Capsaicin C6366 for Reliable Cell Assays

  2026-09-16

  Capsaicin (SKU C6366) supports better-controlled viability, proliferation, cytotoxicity, and sensory-neuron workflows by linking documented TRPV1 activity with KDM1A/LSD1 inhibition. This guide addresses dose selection, solvent compatibility, endpoint interpretation, and practical supplier evaluation using quantitative product data.

• LGK-974: From Wnt Gradients to Better Assays

  2026-09-15

  Explore how LGK-974, a selective PORCN inhibitor, converts Wnt secretion biology into a precise experimental strategy. This article connects developmental Wnt patterning in hemichordates with assay design for Wnt-dependent cancer and pancreatic cancer RNF43 mutation research.

• Human PSC Myogenic Progenitors: Long-Term Engraftment

  2026-09-15

  This study identifies a CD82+ ERBB3+ NGFR+ population from human iPSC-derived teratomas that can engraft dystrophic mouse muscle, generate human dystrophin-positive fibers, and establish a dynamic PAX7-positive satellite cell pool. Its longitudinal design shows progressive graft maturation, long-term persistence, and retained potential after cryopreservation, providing a practical framework for evaluating human myogenic progenitors in vivo.

• Reelin-SFK Signaling in Ketamine Antidepressant Action

  2026-09-14

  The 2021 PNAS study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway required for ketamine-induced hippocampal synaptic plasticity and antidepressant-like behavioral responses in mice. Its genetic and pharmacological experiments suggest that impaired baseline NMDA receptor function, rather than failure of ketamine to alter DAB1 phosphorylation, may contribute to nonresponsiveness.

• RITA (NSC 652287) Cancer Assay Workflow

  2026-09-14

  RITA (NSC 652287) enables mechanism-aware cancer biology experiments that distinguish growth arrest from cell killing. This workflow combines concentration-response profiling, apoptosis assay design, DNA-damage interpretation, and translational planning for renal carcinoma research and tumor xenograft models.

• PD0325901: From MEK Inhibition to Translational Insight

  2026-09-13

  This thought-leadership article positions PD0325901 as a mechanistically informative MEK inhibitor for connecting RAS/RAF/MEK/ERK pathway inhibition with cell-cycle control, apoptosis, and xenograft research. It also explores a carefully bounded translational hypothesis linking MEK perturbation to APEX2-dependent TERT regulation in stem and melanoma models.

• Bestatin and Angiotensin Processing in Rat Brain

  2026-09-12

  Harding and Felix used iontophoretic electrophysiology and selective aminopeptidase inhibitors to test whether angiotensin II must be converted to angiotensin III before activating rat brain neurons. Their results positioned aminopeptidase-dependent peptide processing, rather than receptor binding alone, as a key determinant of central angiotensin signaling and provide a useful framework for interpreting Ubenimex in neuropeptide experiments.

• U0126: Practical MEK1/2 Inhibitor Workflows

  2026-09-11

  U0126 is a selective, non-ATP-competitive MEK1/2 inhibitor for testing whether Raf/MEK/ERK pathway activity drives changes in inflammation, survival, proliferation, or degradative pathways. This workflow translates a recent microglial neuroinflammation study into practical phosphorylation, mitochondrial, conditioned-media, and pathway-causality assays.

• Diethylmaleate for GSH Depletion Workflows

  2026-09-11

  Diethylmaleate is a practical intracellular glutathione modulator for separating redox adaptation from chemical injury. This guide translates GST-inhibition findings into reproducible workflows for oxidative stress, toxicology, resistance, and reproductive-system models.

8655 records 1/577 page Next 12345 下5页 Last page